Roche’s Renal Anemia Studies Show Benefits Of CERA Once-Monthly Dosing
The continuous erythropoietin receptor activator is to be marketed under the trade name Mircera.
The continuous erythropoietin receptor activator is to be marketed under the trade name Mircera.